These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12054573)

  • 1. Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression.
    Kitazawa S; Kitazawa R
    Biochem Biophys Res Commun; 2002 Apr; 293(1):126-31. PubMed ID: 12054573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.
    Kitazawa R; Kitazawa S
    Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
    Liu J; Yang H; Liu W; Cao X; Feng X
    J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
    Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
    Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.
    Kitazawa S; Kajimoto K; Kondo T; Kitazawa R
    J Cell Biochem; 2003 Jul; 89(4):771-7. PubMed ID: 12858342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.
    Abu-Amer Y; Abbas S; Hirayama T
    J Cell Biochem; 2004 Nov; 93(5):980-9. PubMed ID: 15389885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
    J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha expression is transcriptionally regulated by RANK ligand.
    Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z
    J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism.
    Frick KK; Bushinsky DA
    J Bone Miner Res; 2003 Jul; 18(7):1317-25. PubMed ID: 12854843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANKL expression is related to the differentiation state of human osteoblasts.
    Atkins GJ; Kostakis P; Pan B; Farrugia A; Gronthos S; Evdokiou A; Harrison K; Findlay DM; Zannettino AC
    J Bone Miner Res; 2003 Jun; 18(6):1088-98. PubMed ID: 12817763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF; Lie A; Ransjö M
    J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis.
    Kitazawa R; Kitazawa S
    Mol Endocrinol; 2007 Jan; 21(1):148-58. PubMed ID: 17008384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S; Kitazawa R
    J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of mouse RANKL gene expression by Runx2 and vitamin D3.
    Kitazawa R; Mori K; Yamaguchi A; Kondo T; Kitazawa S
    J Cell Biochem; 2008 Dec; 105(5):1289-97. PubMed ID: 18814144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts].
    Tian QX; Huang GY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):418-22. PubMed ID: 15379268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
    Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
    Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.